Skip to main content

GlycoRNA control of immune homeostasis

NIAID - National Institute of Allergy and Infectious Diseases

open
OpenLast verified: 2026-06-20

About This Grant

PROJECT SUMMARY Biopolymers of life fall into four broad categories: proteins, nucleic acids, lipids, and carbohydrates, also called glycans. Hybrid forms of these biopolymers are common, as is the case with glycoproteins and glycolipids on the cell surface. Nearly 80% of secreted or cell surface proteins are glycosylated; some contain up to 50% by mass carbohydrates. Recently, we discovered a new hybrid macromolecule, glycosylated RNA, expressed broadly across many cell and tissue types and is made up of N-glycans modifying small noncoding RNAs. Interestingly, these glycoRNAs are mainly found on the cell surface. While the observation that glycosylation can occur on RNA is transformative, a key question arising from this discovery is what the functional significance of RNA glycosylation is. Nucleic acid sensing is a critical immune surveillance program that monitors for invading pathogens. Innate immune sensors monitor the endosomes and the cytosol for foreign nucleic acids, with TLR3, 7, 8, and 9 sensing nucleic acids that end up in the endosome—these nucleic acids can come from pathogens and dead cells during efferocytosis. Because cells exist in a homeostatic state with glycoRNAs that can access the spaces where TLR sensors are deployed, we hypothesize that glycosylation of mammalian small RNAs prevents immune sensing of glycoRNAs. We plan to test our hypothesis through the innovative approaches proposed in three specific aims. In Aims 1 and 2, we will characterize the features of glycans that enable the “shielding” of glycoRNAs from the endosomal TLR sensing machinery and the mechanism involved. In Aim 3, we will define how pathogenetic bacteria remodel the features of cell surface glycoRNAs and connect this to the functional role of glycoRNAs during the infection of mammalian cells. Altogether, we anticipate that the results generated by this proposal will address a fundamental knowledge gap by establishing the first direct function of glycosylated RNA in the context of immune surveillance and cellular homeostasis.

Grant Summary

GlycoRNA control of immune homeostasis is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $825K for university, nonprofit, healthcare org. Applications are due 2031-05-31 (open). Check eligibility and apply with FindGrants.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $825K

Deadline

2031-05-31

Complexity
High
  1. 1Confirm your organization is eligible for GlycoRNA control of immune homeostasis from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

GlycoRNA control of immune homeostasis: Frequently Asked Questions

Who is eligible for the GlycoRNA control of immune homeostasis?

GlycoRNA control of immune homeostasis is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the GlycoRNA control of immune homeostasis provide?

GlycoRNA control of immune homeostasis provides up to $825K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the GlycoRNA control of immune homeostasis deadline?

Applications for GlycoRNA control of immune homeostasis are due 2031-05-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the GlycoRNA control of immune homeostasis?

To apply for GlycoRNA control of immune homeostasis, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.

Browse More Grants